Salvatore Giovine is the founder of Xilio Therapeutics. Xilio Therapeutics has raised $95M in total funding. Latest round: Series C.
Salvatore Giovine is the Chief Financial Officer (CFO) of Xilio Therapeutics, appointed on March 29, 2021. He brings approximately 20 years of finance leadership experience within the healthcare industry to the role. Prior to joining Xilio, he spent 15 years at Johnson & Johnson, most recently with Janssen Biotech, Inc. leading finance for the NTS U.S. Oncology business.
Full founder directory · Investor directory · Company funding database · Fundraising library